Currently, it is generally accepted that the main functions of GLP-1 mediated by GLP-1R modulation include regulation of nutrition, weight, glucose and lipid metabolism, cardiovascular functions, cognitive functions, as well as stress and emotional reactions
These GLP-1 receptor agonist weight loss injections, originally developed for managing type 2 diabetes, not only promote significant weight loss but may also help with countless obesity-related health risks including pre-diabetes, heart disease, sleep apnea, and more
However, the duration and severity of these side effects can vary among individuals
Tirzepatide is an imbalanced agonist, engaging the GIPR to a greater degree than the GLP-1R in cultured cell systems